Document is current

Article History

Received: 26 August 2024

Accepted: 16 April 2025

First Online: 24 April 2025

Declarations

:

: This study was conducted in accordance with ethical guidelines and principles for research involving human subjects. On November 9th, 2021, the Central Denmark Region Committee on Health Research Ethics reviewed and deemed this study as a quality improvement study (request approval j.no: 204/1-10-72-274-21). As such, the study was determined to be exempt from formal ethical approval under Danish regulations, as it falls within the scope of quality improvement rather than research requiring full ethical oversight. Clinical trial number: Not applicable. All participants were fully informed about the nature, purpose, and scope of the study. Verbal consent was obtained from all participants prior to their inclusion in the study. This approach was deemed appropriate given the minimal risk nature of the study and was conducted in accordance with the guidelines set forth by the Central Denmark Region Committee on Health Research Ethics. The confidentiality and privacy of participants were maintained throughout the study. All data collected were anonymized to prevent the identification of individual participants, and measures were taken to ensure that any information disclosed during the study was protected against unauthorized access. The findings from this study are intended to contribute to the continuous improvement of healthcare practices and patient outcomes within the Central Denmark Region.

: Not applicable.

: The authors declare no competing interests.